IND submission is a major milestone in the life of your drug. We can provide all supporting analytical data to help ensure a smooth application process.
We have the expertise, flexibility, and resources to provide a full range of pharmaceutical API custom development services at every stage of the lifecycle.
We can provide lab-, kilo- and pilot-scale manufacturing for preclinical studies and all phases of clinical trials, supplying milligram to kilogram quantities.
Cambrex brings more than 40 years of generic API manufacturing experience to its pharmaceutical partners. From our sites in Italy, Sweden, and the USA, we are a leading global supplier of generic APIs.
Drug substance tech transfer sounds so simple on the surface, but it’s a complex activity carrying a number of technical, regulatory, and quality risks.
At Snapdragon Chemistry, now part of Cambrex, our chemists specialize in creating custom solutions and technologies to take on your toughest process development and production challenges. This includes expertise in designing and building reactors that enable seamless technology transfer as a process scales up for commercial manufacturing.
At Cambrex, we provide a range of technologies equipped to solve your API manufacturing challenges, and we are flexible enough to handle the most complex molecules.
You can rely on our extensive portfolio of analytical development solutions and testing services to rapidly advance your molecule for the greatest chance of success.
Cambrex offers a comprehensive suite of testing services for complex biopharmaceuticals including standalone analytical R&D, method validation, release testing, ICH stability, and routine QC testing.
We’re solid state chemistry experts who can deliver timely, phase-appropriate solutions to optimize the physical stability of your API, develop a more bioavailable formulation or overcome other challenges.
Cambrex’s experienced analysts are well-equipped to ensure microbial testing is of the highest quality for our customers and delivered with a quick and reliable turnaround.
Cambrex and Q1 Scientific’s stability storage and sample management capabilities provide a variety of pharmaceutical storage conditions, with walk-in and reach-in chambers that meet all ICH Q1A requirements.
Cambrex offers extensive development services tailored to meet your drug product needs in early development. From pre-formulation to Phase II, we ensure your products are developed with speed, flexibility, and quality in mind.
Whether you need rapid development, flexible manufacturing solutions, or high-quality production, Cambrex is your trusted partner for advancing your drug product from concept to the clinic.
Cambrex is here to support you in early-phase development. Our development experts apply their ingenuity and skill to address your unique challenges.
Our teams of creative problem-solvers work closely with you to accelerate drug development timelines, optimize processes, and meet regulatory requirements.
We understand that the commercial phase of drug development can be challenging, especially when it comes to manufacturing at scale and meeting changing market demands.
Cambrex is a leading global supplier of more than 70 generic APIs, as well as intermediates and derivatives.
At Cambrex, we push ourselves to be the best at what we do and achieve superior results for our customers.
We’re proud to have received recognition in the industry for delivering exceptional customer experiences and providing superior technical expertise, all while continuing to maintain the highest level of quality.
Here are some of the recent awards we’ve received from industry organizations in a variety of categories, including customer service, technical expertise, and quality.
We love challenges, and we would like to learn more about yours. Contact us to discuss your project.
We’re honored to announce that Snapdragon Chemistry, a Cambrex company, has been selected as the winner of the API Development award, presented at the 2023 CPhI Pharma Awards in Barcelona, Spain. Snapdragon won for their innovative process development of a continuous flow-manufacturing system, which helps to recycle unwanted elements in the pathway to developing new therapeutics.
Cambrex has been recognized across four categories in the annual CDMO (Contract Development and Manufacturing Organization) Leadership Awards – Quality, Service, Expertise, and Compatibility. Additionally, Cambrex was selected as a “Champion” in the Service category. This marks the ninth consecutive year Cambrex has been acknowledged with an award.
We’re proud to announce Cambrex won the ‘Excellence in Pharma: API Development’ category at the 2019 CPhI Pharma Awards. This marks the third time that Cambrex has won the category in the past 4 years, having previously won in 2016 and 2017. Cambrex was also judged ‘highly commended’ in the same category in 2018.
Cambrex was presented with a high commendation at the 2018 CPhI Pharma Awards for our ‘Continuous Flow Centre of Excellence’ within the Contract Services and Outsourcing category. The entry highlighted the strategic initiative made by Cambrex to develop a continuous flow Center of Excellence in High Point, NC, that aims to strategically fill the shortfall of continuous process development capabilities within the industry.